124 related articles for article (PubMed ID: 29250188)
1. Low miR-210 and
Mei Y; Li Z; Zhang Y; Zhang W; Hu H; Zhang P; Wu M; Huang D
Oncol Lett; 2017 Dec; 14(6):8072-8077. PubMed ID: 29250188
[TBL] [Abstract][Full Text] [Related]
2. Low expression of
Cui L; Gao C; Wang CJ; Liu SG; Wu MY; Zhang RD; Li ZG
Pediatr Hematol Oncol; 2020 Nov; 37(8):732-746. PubMed ID: 32804017
[TBL] [Abstract][Full Text] [Related]
3. Low expressions of ARS2 and CASP8AP2 predict relapse and poor prognosis in pediatric acute lymphoblastic leukemia patients treated on China CCLG-ALL 2008 protocol.
Cui L; Gao C; Zhang RD; Jiao Y; Li WJ; Zhao XX; Liu SG; Yue ZX; Zheng HY; Deng GR; Wu MY; Li ZG; Jia HT
Leuk Res; 2015 Feb; 39(2):115-23. PubMed ID: 25530566
[TBL] [Abstract][Full Text] [Related]
4. CASP8AP2 is a promising prognostic indicator in pediatric acute lymphoblastic leukemia.
Jiao Y; Cui L; Gao C; Li W; Zhao X; Liu S; Wu M; Deng G; Li Z
Leuk Res; 2012 Jan; 36(1):67-71. PubMed ID: 21696825
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of CASP8AP2 gene methylation in childhood acute lymphoblastic leukemia].
Liu FF; Liu X; Wang KL; Li WJ; Deng GR; Gao C; Zhao XX; Wu MY; Cui L; Li ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):6-11. PubMed ID: 25687037
[TBL] [Abstract][Full Text] [Related]
6. Significance of CASP8AP2 and H2AFZ expression in survival and risk of relapse in children with acute lymphoblastic leukemia.
Juárez-Velázquez R; Reyes-León A; Salas-Labadía C; Rivera-Luna R; Velasco-Hidalgo L; López-Hernández G; López-Santiago N; Paredes-Aguilera R; Domínguez-López A; Bernáldez R; Pérez-Vera P
Leuk Lymphoma; 2014 Oct; 55(10):2305-11. PubMed ID: 24397596
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of two CpG sites upstream of CASP8AP2 promoter influences gene expression and treatment outcome in childhood acute lymphoblastic leukemia.
Li ZG; Jiao Y; Li WJ; Deng GR; Cui L; Gao C; Zhao XX; Wu MY; Jia HT
Leuk Res; 2013 Oct; 37(10):1287-93. PubMed ID: 23953914
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic Significance of Joint Detection of miR-210 and Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia].
Mei YY; Li ZG; Zhang Y; Zhang WL; Zhang PW; Wang N; Huang DS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):66-71. PubMed ID: 28245377
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.
Ghodousi ES; Rahgozar S
J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor E2F3a regulates
Liu FF; Wang KL; Deng LP; Liu X; Wu MY; Wang TY; Cui L; Li ZG
Cancer Cell Int; 2018; 18():40. PubMed ID: 29568235
[TBL] [Abstract][Full Text] [Related]
13. Interaction between CASP8AP2 and ZEB2-CtBP2 Regulates the Expression of
Wang CJ; Jia MZ; Deng LP; Li WJ; Zhang Q; Zhang TJ; Li SY; Cui L; Li ZG
Pediatr Hematol Oncol; 2022 Sep; 39(6):549-560. PubMed ID: 35139734
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia.
Rzepiel A; Kutszegi N; Gézsi A; Sági JC; Egyed B; Péter G; Butz H; Nyírő G; Müller J; Kovács GT; Szalai C; Semsei ÁF; Erdélyi DJ
J Transl Med; 2019 Nov; 17(1):372. PubMed ID: 31727091
[TBL] [Abstract][Full Text] [Related]
15. Interaction of E2F3a and CASP8AP2 Regulates Histone Expression and Chemosensitivity of Leukemic Cells.
Jin FF; Wang CJ; Cui L; Liu FF; Wang KL; Li WJ; Li ZG
J Pediatr Hematol Oncol; 2023 Apr; 45(3):e339-e344. PubMed ID: 36162009
[TBL] [Abstract][Full Text] [Related]
16. [Research Progress on Expression Regulation, Function and Clinical Significance of CASP8AP2 Gene].
Li ZG; Wu MY; Jia HT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):557-61. PubMed ID: 25948224
[TBL] [Abstract][Full Text] [Related]
17. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
Lin X; Wang Z; Wang Y; Feng W
Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
[TBL] [Abstract][Full Text] [Related]
18. mRNA overexpression of
Azizi Z; Rahgozar S; Moafi A; Dabaghi M; Nadimi M
Biomed Rep; 2015 May; 3(3):371-374. PubMed ID: 26137238
[No Abstract] [Full Text] [Related]
19. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G
Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900
[TBL] [Abstract][Full Text] [Related]
20. E2F3a gene expression has prognostic significance in childhood acute lymphoblastic leukemia.
Wang KL; Mei YY; Cui L; Zhao XX; Li WJ; Gao C; Liu SG; Jiao Y; Liu FF; Wu MY; Ding W; Li ZG
Eur J Haematol; 2014 Oct; 93(4):281-9. PubMed ID: 24758291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]